U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,490
-910 (-4.46%)
At close: Apr 28, 2026

U2Bio Revenue

In the year 2025, U2Bio had annual revenue of 25.59B KRW with 2.21% growth. U2Bio had revenue of 6.27B in the quarter ending December 31, 2025, with 0.11% growth.

Revenue
25.59B
Revenue Growth
+2.21%
P/S Ratio
12.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
310.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202525.59B552.73M2.21%
Dec 31, 202425.04B-5.75B-18.68%
Dec 31, 202330.79B-38.22B-55.38%
Dec 31, 202269.01B58.01B527.29%
Dec 31, 201411.00B1.59B16.90%
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MNtech 538.53B
Lumir 10.57B
NAU Robotics Co.,Ltd 12.53B
Huons 620.77B
MEGAELECTRONICS 96.49B
KNJ Co., Ltd. 84.44B
COOCON 73.02B
Saltlux 41.64B
Revenue Rankings